TeselaGen
3 known investors
TeselaGen provides a platform for automated biological design and DNA cloning that integrates with existing laboratory tools via API and Python SDK. The platform serves biotech teams working on synthetic biology, protein engineering, and fermentation optimization.
AI & Machine LearningBiotechSaaS
Investors Β· 3
Non-dilutive funding Β· 3 SBIR/STTR awards
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2014 | $750K |
| National Science Foundation | Phase I | 2013 | $150K |
| National Science Foundation | Phase I | 2012 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does TeselaGen do?
- TeselaGen provides a platform for automated biological design and DNA cloning that integrates with existing laboratory tools via API and Python SDK. The platform serves biotech teams working on synthetic biology, protein engineering, and fermentation optimization.
- Who are TeselaGen's investors?
- TeselaGen's investors include Baruch Future Ventures, Taram Capital, WeBoost.